Silo pharma announces participation on webull corporate communications service platform

Webull's investor community can now access the silo profile for real-time data and investor communications englewood cliffs, nj, june 02, 2023 (globe newswire) -- silo pharma, inc. (nasdaq: silo) (“the company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that it is now actively participating on the webull corporate communications service (ccs) platform. the silo pharma portal on webull offers an additional channel for direct investor communication and audience engagement, including q&a.
SILO Ratings Summary
SILO Quant Ranking